New rules approved by the European Parliament require safety features on the packaging of medicines

The Falsified Medicines Directive requires safety features to be on packaging by February 2019

The European Parliament and Council has published a new Delegated Regulation (EU2016/161) to supplement the Falsified Medicines Directive (FMD). It introduces two mandatory safety features that will allow medicines to be verified and authenticated, and should appear on the packaging of all relevant medicines by 9 February 2019.

The two safety features include a unique identifier and an anti-tampering device that must be applied to every pack of medicine. The unique number means that a product can be verified at any point in the supply chain by scanning with a barcode reader, for example.

GS1 UK can offer you support and guidance on what you need to do in order to meet new regulations. Find out more about membership and our training academy.